NTLA | NASDAQ Stock Exchange

Intellia Therapeutics
+ Share

Intellia Therapeutics has broken the first resistance point ($32.57) [Bullish]
Pivot Points /
Intellia Therapeutics has broken the first resistance point ($32.57) [Bullish]

Intellia Therapeutics has broken the first resistance point ($32.57) [Bullish]. Look for a long limit order entry near this point. Exit price for NTLA should be set @$33.12 & Stoploss for Intellia Therapeutics should be set between $30.52 & $29.97

Traders are currently accumulating Intellia Therapeutics
Accumulation / Distribution /
Traders are currently accumulating Intellia Therapeutics

[BULLISH]: Intellia Therapeutics current accumulation has given strength to the share price and the continuation of bullish trading conditions. Currently, the ADLINE is 5.6374e+006.

Fibonacci Extensions /
Intellia Therapeutics has broken above the 161.8% extension level ($11.56) [Bearish]

Intellia Therapeutics has moved above the 161.8% level ($11.56) [Bearish]. Look for a short limit order entry near this point. Exit price for NTLA should be set @$12.76 & short position stoploss for Intellia Therapeutics should be set at $10.36

Volume Rate of Change /
Negative VROC: Price is lower for Intellia Therapeutics than 14 days ago

[BEARISH]: Intellia Therapeutics currently has negative rate of change of -31%. This means the current volume is less than the price 14 days ago and therefore losing momentum. Currently, the return on momentum is 1.2%.

Simple Moving Average /
[Bullish]: SMA(5) is serving as a support line for Intellia Therapeutics

[BULLISH]: Intellia Therapeutics currently has a confirmed uptrend. Recent trading has caused the SMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SMA5 is 1.2%.

Average Directional Movement /
Intellia Therapeutics: Average Directional Index (20.45) has confirmed a weak trend is present

[Weak Trend]: ADX for NTLA has confirmed a weak trend is present. Intellia Therapeutics has an ATR(14) of 1.732, a DX of 11.77 & an ADX(14) of 20.45

Top companies for
NASDAQ Stock Exchange
Open Tod Vs Close Tod /
NTLA: Over the last 12 months there has been 43 trading days giving a confirmation ratio of 16.3%.

[BULLISH STRONG]: Intellia Therapeutics opened in the lower part of daily range at 33.1% & closed in the upper part of the trading range at 73.1%. This suggests the buyers were in control all day. Over the last 12 months there has been 43 trading days with the opening price in the lower shadow & the closing the price in the upper shadow giving a confirmation ratio of 16.3%. Over the last month there has been 2 trading days with the opening price in the lower price range & the closing the price in the upper price range giving a confirmation ratio of 14.3%.

Moving Average Envelope /
Upper envelopes overbought signal had been maintained for Intellia Therapeutics

[BEARISH]: Intellia Therapeutics current trading has maintained the Envelope Bands to overbought status and signalled the continuation of the bearish trading conditions. Currently, the Upper Band is 31.1325.

Positive ROC for Intellia Therapeutics is a leading indicator for continued price rise
Rate of Change /
Positive ROC for Intellia Therapeutics is a leading indicator for continued price rise

[BULLISH]: Intellia Therapeutics currently has positive rate of change of 17.032%. This means the current price is greater than the price 14 days ago and therefore gaining momentum & is a leading indicator of price movement in the upward direction

Momentum continues to fall for Intellia Therapeutics signalling an downtrend will persist
Momentum /
Momentum continues to fall for Intellia Therapeutics signalling an downtrend will persist

[BEARISH]: Intellia Therapeutics currently has negative momentum of -0.58 This means the current price is less than the price 5 days ago and therefore losing momentum. Currently, the return on momentum is 1.2%.The largest downward momentum rally for the last 3 months is 3 days producing a return of 0%.

Range Tod Vs Range Yest /
Intellia Therapeutics: Range Performance (-13.9)

[WEAK BEARISH]: Intellia Therapeutics buyers are becoming less eager. This is the first day buyers have decreased eagerness for NTLA reducing strength to an uptrend in the first timeframe. The biggest price range this month has been $5.8500 & the greatest daily price range this year has been $17.7300. The price range ratio this week versus the quarterly price range is 0.6x & the price range ratio this month versus the year to date price range is 0.3x.

Percentage Volume /
Intellia Therapeutics: Percentage Volume Oscillator @-17.24 [Bearish]

[BEARISH]: Intellia Therapeutics currently has negative PVO -17.24%. The recent volume is losing momentum through a fall on the short term exponential moving average. Currently, the return on PVO is 12%.

On Balance Volume /
Intellia Therapeutics is being actively accumulated based on OBV

[BULLISH]: Intellia Therapeutics current price has highlighted recent accumulation. Currently, the OBV is 4.44248e+006.

Intellia Therapeutics: ARO(40) has signalled an uptrend is current
Aroon Oscillator /
Intellia Therapeutics: ARO(40) has signalled an uptrend is current

[BULLISH]: Intellia Therapeutics has a current ARO(25) of 40. This has change -40 points from yesterday.

[Downtrend]: Average True Range @1.732 has confirmed an downtrend for NTLA
Average True Range /
[Downtrend]: Average True Range @1.732 has confirmed an downtrend for NTLA

[Bearish]: Average True Range has confirmed an downtrend is present. Intellia Therapeutics has a TR of 1.3, and an ATR(14) of 1.732.

Sine Weighted Moving Average /
Intellia Therapeutics is in a short term uptrend with the closing price @$32.02

[BULLISH]: Intellia Therapeutics currently has a confirmed uptrend. Recent trading has caused the SWMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SWMA5 is 1.2%.

Detrended Price Oscillator /
The simple moving average and past price for NTLA has confirmed bullish trading conditions

[BULLISH]: Intellia Therapeutics currently has a confirmed uptrend. Price is currently above the displaced moving average for NTLA. Currently, the return on DPO20 is 1.2%.

Elders Force Index /
Elders Force Index (-15776) has signalled bearish conditions in recent trading for NTLA

[BEARISH]: Intellia Therapeutics current price has highlighted recent selling pressure. Currently, the Elders Force Index is -15776.

Intellia Therapeutics: Daily price range is 1.3 [Downtrend]
Price Range /
Intellia Therapeutics: Daily price range is 1.3 [Downtrend]

[BEARISH]: Intellia Therapeutics current downtrend in the first timeframe. Currently, the Range is $1.3.

Intellia Therapeutics was easily moved upward on low volume in recent trading [Bullish]
Ease of Movement /
Intellia Therapeutics was easily moved upward on low volume in recent trading [Bullish]

[BULLISH]: Intellia Therapeutics current price have moved upwards on low volume. Currently, the Ease of Movement is 246.521

Intellia Therapeutics: Daily low price is $31.07 [Lower Low]
Low Price /
Intellia Therapeutics: Daily low price is $31.07 [Lower Low]

[BEARISH]: Intellia Therapeutics current uptrend in the first timeframe. Currently, the Low is $31.07 (2.9 %).

Elder Ray Index /
Intellia Therapeutics: Elder Ray Index is 1.421 [Bullish]

[BULLISH]: Intellia Therapeutics Elder Ray Index is signalling a Bullish movementERI is 1.421 indicating bull power. Prices are being driven above the consensus of value for NTLA during the last trading session [Buying Pressure]

Opening Price /
[Bearish]: Opening performance for NTLA of 1.0 % was achieved in last trading session

NTLA: OPEN Current Signal -> (1) 20 Jul: BEARISH (2) 19 Jul: BULLISH (3) 18 Jul: BEARISH

Stochastic Oscillator /
Stochastic Overbought signal continues for Intellia Therapeutics indicating downward price movement is likely

[BEARISH]: Intellia Therapeutics is currently Overbought highlighting the potential for a short term trend reversal in the downward direction.

Exponential Moving Average /
[Bullish]: EMA(5) is serving as a support line for Intellia Therapeutics

NTLA: EMA(5) Recent Trading -> (1) 20 Jul: 31.5110 (2) 19 Jul: 31.2565 (3) 18 Jul: 31.0648

NTLA: Moving Average Convergence Divergence [Bearish]
MACD /
NTLA: Moving Average Convergence Divergence [Bearish]

NTLA: MACD Current Signal -> (1) 20 Jul: BEARISH (2) 19 Jul: BEARISH CROSSOVER (3) 18 Jul: BEARISH CROSSOVER

Intellia Therapeutics: Buyers are in control at the market close.
Close Tod Vs Range Tod /
Intellia Therapeutics: Buyers are in control at the market close.

[BULLISH]: Intellia Therapeutics buyers are in control at the market close. There has been 4 consecutive days of prices closing in the upper part of the trading range for Intellia Therapeutics adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 103 trading days with the closing price in the upper part of the range giving a confirmation ratio of 39.2%. Over the last month there has been 11 trading days with the closing price in the upper range giving a confirmation ratio of 78.6%. Currently this quarter, closing price has spent 11 days in the upper price range compared to 2 days in the lower range giving a ratio of 5.5x.

Closing Price /
Recent trading for Intellia Therapeutics has surpassed the previous close by 1.2 %

[BULLISH]: Intellia Therapeutics current uptrend in the first timeframe. Currently, the Close is $32.02.

See More   See more results
back to top